The influence of sucralfate on ibuprofen absorption in healthy adult males

A. Lopez Anaya, Michael Mayersohn, K. A. Conrad, D. C. Dimmitt

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Sucralfate (Carafate®) is a new anti-ulcer agent the effects of which are mediated locally in the gastrointestinal tract. The use of this compound in conjunction with ulcerogenic drugs such as ibuprofen may represent a means of reducing gastrointestinal irritation. Combined oral therapy, however, requires evaluation of a potential interaction in absorption between those agents. The purpose of this study was to examine the influence of sucralfate coingestion on ibuprofen absorption. Twelve normal, healthy male subjects ingested a single oral 400 mg dose of ibuprofen alone or with sucralfate given as 1 g doses four times a day for 2 days prior to and during the study. Ibuprofen serum concentrations were measured for 12 hours following dosing. Parameters associated with rate of absorption (i.e. C(max), t(max), K(a)) were significantly altered in the presence of sucralfate (p < 0.05). In contrast, the relative bioavailability of ibuprofen was not significantly different between treatments (p > 0.05). Therefore, sucralfate does not alter the extent of ibuprofen absorption and would not be expected to change the response to that anti-inflammatory agent.

Original languageEnglish (US)
Pages (from-to)443-451
Number of pages9
JournalBiopharmaceutics and Drug Disposition
Volume7
Issue number5
StatePublished - 1986

Fingerprint

Sucralfate
Ibuprofen
Anti-Ulcer Agents
Gastrointestinal Tract
Healthy Volunteers
Anti-Inflammatory Agents
Serum
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The influence of sucralfate on ibuprofen absorption in healthy adult males. / Lopez Anaya, A.; Mayersohn, Michael; Conrad, K. A.; Dimmitt, D. C.

In: Biopharmaceutics and Drug Disposition, Vol. 7, No. 5, 1986, p. 443-451.

Research output: Contribution to journalArticle

Lopez Anaya, A. ; Mayersohn, Michael ; Conrad, K. A. ; Dimmitt, D. C. / The influence of sucralfate on ibuprofen absorption in healthy adult males. In: Biopharmaceutics and Drug Disposition. 1986 ; Vol. 7, No. 5. pp. 443-451.
@article{436d402d521143168cd882b72ac31ccf,
title = "The influence of sucralfate on ibuprofen absorption in healthy adult males",
abstract = "Sucralfate (Carafate{\circledR}) is a new anti-ulcer agent the effects of which are mediated locally in the gastrointestinal tract. The use of this compound in conjunction with ulcerogenic drugs such as ibuprofen may represent a means of reducing gastrointestinal irritation. Combined oral therapy, however, requires evaluation of a potential interaction in absorption between those agents. The purpose of this study was to examine the influence of sucralfate coingestion on ibuprofen absorption. Twelve normal, healthy male subjects ingested a single oral 400 mg dose of ibuprofen alone or with sucralfate given as 1 g doses four times a day for 2 days prior to and during the study. Ibuprofen serum concentrations were measured for 12 hours following dosing. Parameters associated with rate of absorption (i.e. C(max), t(max), K(a)) were significantly altered in the presence of sucralfate (p < 0.05). In contrast, the relative bioavailability of ibuprofen was not significantly different between treatments (p > 0.05). Therefore, sucralfate does not alter the extent of ibuprofen absorption and would not be expected to change the response to that anti-inflammatory agent.",
author = "{Lopez Anaya}, A. and Michael Mayersohn and Conrad, {K. A.} and Dimmitt, {D. C.}",
year = "1986",
language = "English (US)",
volume = "7",
pages = "443--451",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - The influence of sucralfate on ibuprofen absorption in healthy adult males

AU - Lopez Anaya, A.

AU - Mayersohn, Michael

AU - Conrad, K. A.

AU - Dimmitt, D. C.

PY - 1986

Y1 - 1986

N2 - Sucralfate (Carafate®) is a new anti-ulcer agent the effects of which are mediated locally in the gastrointestinal tract. The use of this compound in conjunction with ulcerogenic drugs such as ibuprofen may represent a means of reducing gastrointestinal irritation. Combined oral therapy, however, requires evaluation of a potential interaction in absorption between those agents. The purpose of this study was to examine the influence of sucralfate coingestion on ibuprofen absorption. Twelve normal, healthy male subjects ingested a single oral 400 mg dose of ibuprofen alone or with sucralfate given as 1 g doses four times a day for 2 days prior to and during the study. Ibuprofen serum concentrations were measured for 12 hours following dosing. Parameters associated with rate of absorption (i.e. C(max), t(max), K(a)) were significantly altered in the presence of sucralfate (p < 0.05). In contrast, the relative bioavailability of ibuprofen was not significantly different between treatments (p > 0.05). Therefore, sucralfate does not alter the extent of ibuprofen absorption and would not be expected to change the response to that anti-inflammatory agent.

AB - Sucralfate (Carafate®) is a new anti-ulcer agent the effects of which are mediated locally in the gastrointestinal tract. The use of this compound in conjunction with ulcerogenic drugs such as ibuprofen may represent a means of reducing gastrointestinal irritation. Combined oral therapy, however, requires evaluation of a potential interaction in absorption between those agents. The purpose of this study was to examine the influence of sucralfate coingestion on ibuprofen absorption. Twelve normal, healthy male subjects ingested a single oral 400 mg dose of ibuprofen alone or with sucralfate given as 1 g doses four times a day for 2 days prior to and during the study. Ibuprofen serum concentrations were measured for 12 hours following dosing. Parameters associated with rate of absorption (i.e. C(max), t(max), K(a)) were significantly altered in the presence of sucralfate (p < 0.05). In contrast, the relative bioavailability of ibuprofen was not significantly different between treatments (p > 0.05). Therefore, sucralfate does not alter the extent of ibuprofen absorption and would not be expected to change the response to that anti-inflammatory agent.

UR - http://www.scopus.com/inward/record.url?scp=0022472833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022472833&partnerID=8YFLogxK

M3 - Article

C2 - 3779035

AN - SCOPUS:0022472833

VL - 7

SP - 443

EP - 451

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 5

ER -